## Clinical Context This patient has **chronic rheumatic mitral regurgitation (MR)** that is mild, hemodynamically stable (normal LV size and function), and asymptomatic. The key question is: what prevents disease progression and complications? ## Management of Chronic Asymptomatic Rheumatic MR ```mermaid flowchart TD A[Chronic RHD with MR]:::outcome --> B{Symptomatic?}:::decision B -->|Yes| C[Consider surgical intervention]:::action B -->|No| D{LV dysfunction<br/>or dilatation?}:::decision D -->|Yes| E[Consider early surgery]:::action D -->|No| F[Medical management]:::action F --> G[Secondary prophylaxis with penicillin]:::action F --> H[Regular echo surveillance<br/>6-12 monthly]:::action F --> I{Atrial fibrillation?}:::decision I -->|Yes| J[Anticoagulation]:::action I -->|No| K[No anticoagulation needed]:::action ``` ## Key Point: **Secondary prophylaxis with benzathine penicillin G** is the cornerstone of management in asymptomatic chronic RHD. It prevents recurrent ARF and slows disease progression. The duration depends on whether carditis was present in the initial ARF. ## High-Yield: - **Secondary prophylaxis duration:** If carditis was present → continue until age 40 or 5 years after last ARF (whichever is longer); if no carditis → 5 years or until age 21 - **Anticoagulation in RHD:** Indicated ONLY in presence of atrial fibrillation, LV thrombus, or mechanical prosthesis — NOT for asymptomatic MR alone - **Surveillance strategy:** Asymptomatic patients with mild-to-moderate MR and normal LV function → echo every 6–12 months to detect progression - **Surgical indications in MR:** Symptoms, LV dilatation (LVEDD >55 mm), LV dysfunction (EF <60%), or new-onset atrial fibrillation ## Clinical Pearl: The absence of atrial fibrillation is a protective factor against thromboembolism in RHD. Anticoagulation is NOT indicated in sinus rhythm with asymptomatic MR, even with LA enlargement, unless there is evidence of thrombus or hemodynamic decompensation. ## Rationale for Correct Answer In asymptomatic chronic RHD with stable hemodynamics, the priority is to (1) prevent recurrent ARF via secondary prophylaxis, and (2) monitor for progression via serial echocardiography. Surgical intervention is premature in an asymptomatic patient with normal LV function. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.